A key feature of Plasmodium falciparum, the parasite causing the most severe form of malaria in humans, is its ability to export parasite molecules onto the surface of the erythrocyte. The major virulence factor and variant surface protein PfEMP1 (P.falciparum erythrocyte membrane protein 1) acts as a ligand to adhere to endothelial receptors avoiding splenic clearance. Since the erythrocyte is devoid of protein transport machinery, the parasite provides infrastructure for trafficking across membranes it traverses. In this study, we show that the P.falciparum skeleton binding protein 1 (PfSBP1) is required for transport of PfEMP1 to the P.falciparuminfected erythrocyte surface. We present evidence that PfSBP1 functions at the parasitophorous vacuole membrane to load PfEMP1 into Maurer's clefts during formation of these structures. Furthermore, the major reactivity of antibodies from malaria-exposed multigravid women is directed towards PfEMP1 since this is abolished in the absence of PfSBP1.
Introduction
Plasmodium falciparum is the causative agent of the most severe form of malaria in humans resulting in severe morbidity and mortality with over two million deaths each year 1 . Upon invasion into erythrocytes P.falciparum modifies the host cell by export of parasite-encoded proteins across the parasitophorous vacuole membrane (PVM) into the erythrocyte cytosol and some of these are incorporated beneath and transported onto the host membrane 2, 3 . The parasite proteins on the erythrocyte surface are exposed to the host immune system and play a role in pathogenesis of infection 4 .
Transport of proteins to the erythrocyte cytoskeleton and surface is a multi-step process involving trafficking across the parasite membrane, PVM and erythrocyte cytosol 5, 6 . Here they associate with membranous structures known as Maurer's clefts before reaching their destination. The surface of the infected erythrocyte becomes punctuated with electron dense elevations called knobs 7, 8 . These structures provide a platform for variant P.falciparum erythrocyte membrane protein-1 (PfEMP1) [9] [10] [11] . PfEMP1 mediates adhesion by binding to host receptors such as CD36 and chondroitin sulfate A (CSA) 12, 13 . Other proteins, such as knob associated histidine-rich protein (KAHRP) and P.falciparum erythrocyte membrane protein 3 (PfEMP3), are exported through the PVM using a hydrophobic signal sequence and a pentameric PEXEL (Plasmodium export element) at the N-terminus, required for translocation across the PVM 2,3,14 .
PfEMP1 contains a PEXEL-like sequence at the N-terminus although a second sequence has been suggested in trafficking of this protein to the erythrocyte surface 2, 3 . This protein does not have a hydrophobic signal sequence and enters the endoplasmic reticulum (ER) via a hydrophobic transmembrane segment towards the C-terminus of the protein 15 . The PEXEL-like sequence and transmembrane region may be sufficient for trafficking of PfEMP1 to the surface of the parasite-infected erythrocyte; however, this has not been confirmed 2, 15 .
Interestingly, there are some proteins exported to the parasite-infected erythrocyte that do not contain a PEXEL and it is not clear how they are translocated. One of these molecules, the 48 kDa P.falciparum skeleton binding protein 1 (PfSBP1) is a type 2 integral membrane protein localised to Maurer's clefts 16 . The absence of a signal sequence and inhibition of export with brefeldin A suggests it is transported via the ERGolgi and inserted into Maurer's clefts membrane. PfSBP1 has been suggested to anchor
Maurer's clefts to the erythrocyte cytoskeleton 16 or prevent early rupture of the erythrocyte membrane by interacting with host proteins 17 . In this work, we address the role of PfSBP1 and show that it is required for export of PfEMP1 into the erythrocyte cytosol to Maurer's clefts.
Materials and methods

Plasmids constructs, parasite strains, culture conditions and transfection
The pHHT-TK-∆SBP1 plasmid was derived from pHHT-TK 18 by insertion of a 5' (923 bp) and 3' (818 bp) segment of PfSBP1 with oligonucleotide primers aw549/aw500 and aw200/201, respectively. For complementation full length PfSBP1 was amplified using the primer pair aw779/780 and then cloned using Xho I/Xma I.
The PfEMP1 plasmid was assembled using Multisite recombination as described 19 . Entry vectors PfHSP86 5'-pENTR4/1 19 , Pf5B1+ N-term TOPO pENTR 20 , Pf5B1 TM-ATS Cterm pENTR2/3 20 , and the destination vector pHBlR-3/4 19 were used. The resulting BHPfEMP1-YFP is identical to the PfEMP1-YFP as published 20 , with the exception that hDHFR has been replaced blasticidin-S-deaminase and selected with 3 µg/ml blasticidin (Fig. 6C) .
P.falciparum asexual stages were maintained in human 0+ erythrocytes. CS2 is a clone of the It isolate 13 . It adheres to CSA and hyaluronic acid 13, 21 in vitro and is recognized by antibodies among pregnant women exposed to placental malaria 29 . Prior to transfection CS2 was re-selected for adhesion to bovine trachea CSA (Sigma). Transfection with 80 µg of purified plasmid DNA (Qiagen) and selection for stable transfectants was carried out as described 18 .
Oligonucleotides and DNA analysis Underlined are restriction sites introduced for cloning.
Genomic DNA was prepared with the DNeasy Tissue Kit (Qiagen) and subjected to Southern Blot analysis using standard protocols.
SDS-PAGE and immunoblot analysis
Synchronised trophozoite cultures were saponin lysed and the pellet washed three times in PBS and taken up in SDS sample buffer (Invitrogen). Proteins were separated on 3-8%
Tris-Acetate or 10% Bis-Tris gels (Invitrogen). Western blotting to nitrocellulose (0.45µm, Schleicher and Schuell) was performed according to standard protocols.
Antibodies used were mouse anti-SBP1 (1:2000), rabbit anti-HSP70 (1:4000) 22 , rabbit anti-ATS (1:1000) and mouse monoclonal anti-ATS 1B/98-6H1-1 (1:200). Both anti-ATS antibodies were preabsorbed on erythrocyte ghosts. Horseradish peroxidase-coupled sheep anti-rabbit Ig or anti-mouse Ig (1:1000, Chemicon) were used as secondary antibodies.
CSA binding assay and Trypsin cleavage assay
Binding assays were performed using P. falciparum infected erythrocytes at 3% parasitemia and 4% hematocrit 23 . For trypsin cleavage parasites were synchronised by sorbitol, grown to trophozoite stage and harvested by magnet cell sorting (CS columns;
Mitenyi Biotec) then treated with either TPCK-treated trypsin (Sigma) (1 mg/ml in PBS)
or incubated in PBS for 1 h at 37°C. After incubation soy bean trypsin inhibitor (Sigma) (10mg/ml in PBS) was added followed by incubation at room temperature for 15 min.
Cell pellets were extracted with Triton X-100 (1%) and subsequently with sodium dodecylsulfate (SDS, 2%) as described 24 .
Fractionation of infected erythrocytes
For saponin lysis, 2x10 7 infected erythrocytes (enriched via Plasmagel floatation 25 ) were incubated in a final concentration of 0.09% saponin (Kodak) for 10 min on ice then centrifuged at 4000xg for 5 min. The supernatant was resuspended in SDS sample buffer (Invitrogen) and the pellet washed twice in PBS before resuspending in SDS sample buffer.
The Triton-X 100/SDS extraction was performed as described for the trypsin cleavage assay, without the cells being subjected to a prior trypsin treatment. For the permeabilization of infected erythrocytes with Streptolysin-O (SLO), the haemolytic activity of SLO was determined and 2 x 10 7 were incubated with 4 or 2 haemolytic units in PRMI-1640 medium as described 26 . Samples were analysed via Western blot.
Electron microscopy and Immunofluorescence microscopy
For scanning electron and transmission electron microscopy parasite-infected erythrocytes were tightly synchronised and processed by standard methods 27 
Results
Disruption of the PfSBP1 gene in P.falciparum-infected erythrocytes
To determine the function of PfSBP1 in P.falciparum we constructed a plasmid to integrate into the gene (PFE0065w) by double crossover recombination (Fig. 1A ) 18 . The pHHT-TK∆SBP1 plasmid was transfected into P.falciparum CS2-infected erythrocytes and parasites obtained with the hDHFR cassette integrated by homologous recombination resulting in disruption of PfSBP1 (Fig. 1A) . This was confirmed by Southern blot hybridisation (Fig. 1B ).
CS2∆SBP1 transgenic parasites do not express PfSBP1
To confirm gene disruption had resulted in loss of PfSBP1 expression we performed immunoblots with anti-PfSBP1 ( Maurer's clefts develop normally in the absence of PfSBP1
To determine if trafficking of other proteins had been affected in the absence of PfSBP1
and whether Maurer's clefts showed a typical morphology we used both immunofluorescence with antibodies to the Maurer's clefts resident proteins PfSBP1 19 and PfMAHRP1 37 and electron microscopy. In both parental and CS2∆SBP1 transgenic parasite-infected erythrocytes anti-MAHRP1 antibodies showed the same punctate pattern as anti-PfSBP1 antibodies in CS2 ( Fig PfSBP1 mutants display knobs on the surface of the parasite-infected erythrocyte KAHRP is the major component of the knob structure and this protein is exported through the PVM into the erythrocyte cytosol where it binds to Maurer's clefts before assembly underneath the erythrocyte membrane 14 . In order to determine if loss of PfSBP1 function in CS2∆SBP1 affected trafficking of KAHRP and assembly into knobs we employed immunofluorescence with anti-KAHRP antibodies and scanning electron microscopy ( Fig. 3A) . Both CS2 and CS2∆SBP1 showed rim fluorescence suggesting KAHRP was trafficked to the underside of the host cell membrane (Fig. 3A) .
Additionally, CS2∆SBP1 infected erythrocytes showed typical knobs on the surface of the host cell compared to CS2 ( PfEMP1 is not trafficked to the surface of CS2∆SBP1-infected erythrocytes
To examine if the inability of CS2∆SBP1 to adhere to CSA was due to absence or altered levels of PfEMP1 on the surface of parasite-infected erythrocytes, we used an assay allowing detection of the pool of protein exposed on the surface by virtue of its sensitivity to trypsin cleavage 31 . Cultures were treated with or without trypsin and PfEMP1 protein detected using antibody to the conserved acidic terminal segment (ATS), a region located on the cytosolic face of the infected erythrocyte (Fig. 5A) . The anti-ATS antibody detected an approximately 300 kDa protein representing full length protein in CS2. It also cross-reacts with a blood cell component (most likely spectrin) as shown by comparison with uninfected erythrocytes (Fig. 5A ). In the parental CS2 only full length PfEMP1 (surface exposed and non-exposed pools) was observed in the absence of trypsin ( Fig. 5A (-trypsin) ), whereas after trypsin cleavage, products of 83 kDa could be detected ( Fig. 5A (+ trypsin) ). These represent the protected intracellular PfEMP1 domain (transmembrane region and ATS) after cleavage of the surface exposed PfEMP1.
The 300 kDa band after trypsin treatment corresponds to the cytoplasmic pool of PfEMP1. In contrast, CS2∆SBP1-infected erythrocytes showed no protein truncations after trypsin cleavage suggesting there was no PfEMP1 on the surface (Fig. 5A ). This was confirmed using a mouse anti-ATS antibody. The absence of PfEMP1 was consistent with inability of these cells to bind to CSA.
It has been shown previously that PfEMP1 has different solubility characteristics during trafficking to the erythrocyte membrane as a consequence of its association with different compartments 32 . To compare the solubility of PfEMP1 in parent and CS2∆SBP1 we used saponin lysis of infected erythrocytes. The pellet fraction includes proteins associated with the parasite and parasitophorous vacuolar and erythrocyte membranes (Fig. 5B ).
PfEMP1 was detected in the pellet of CS2, which mainly represents the membraneassociated pool of PfEMP1. In the absence of PfSBP1 the CS2∆SBP1-infected erythrocytes showed significantly less PfEMP1 in the saponin pellet consistent with absence of membrane-associated PfEMP1 in and on the erythrocyte surface. In contrast, in CS2∆SBP1 more PfEMP1 was found in the supernatant relative to the amount detectable in the pellet. To see whether this correlates with the membrane association of PfEMP1 fractionation was performed (Fig. 5C ). The Triton X-100 soluble fraction of the parental CS2 trophozoite infected cells contained only a small amount of PfEMP1; as previously reported 10 the majority of PfEMP1 is found in the SDS soluble fraction.
However, the amount of PfEMP1 found in the Triton X-100 soluble fraction of the CS2∆SBP1-infected erythrocytes was significantly increased arguing for a larger pool of tightly membrane-associated PfEMP1 in CS2 than in CS2∆SBP1-infected erythrocytes.
To determine the nature of the membrane association we permeabilised erythrocytes infected with CS2 and CS2∆SBP1 parasites with streptolysin O (SLO). SLO permeabilises the erythrocyte membrane and leaves membranes of parasitic origin intact (eg. parasite membrane, parasitophorous vacuole or Maurer's clefts) (Fig. 5D) . A small but observable increase of soluble PfEMP1 is found in the supernatant of SLO permeabilised CS2∆SBP1-infected erythrocytes relative to the CS2-infected cells. These results suggest a small quantity of PfEMP1 in CS2∆SBP1 is present in the erythrocyte in a soluble state that cannot associate with the membranes of parasite induced compartments or the erythrocyte membrane due to lack of PfSBP1 function.
To further establish the finding that there was no detectable PfEMP1 present on CS2∆SBP1 infected erythrocytes we determined the level of antibody reactivity to the host cell surface using sera from multigravid women resident in a malaria-endemic area of Papua New Guinea. Multigravid women are generally exposed to P. falciparum parasites that present novel antigenic phenotypes that adhere to the receptor CSA in the placenta 36 . These sera should react strongly with the surface of CS2-infected erythrocytes since they express the var2csa encoded PfEMP1, a known ligand for CSA. Levels of IgG binding among multigravid women's sera were significantly higher for CS2 parent compared to CS2∆SBP1 (mean ± SEM fluorescence 483±116 versus 80.7±15.2, respectively; p<0.004, Wilcoxon's signed-rank rum test) (Fig. 5C ). IgG binding was higher to CS2 than CS2-∆SBP1 infected erythrocytes for 9 of 10 PNG samples tested (fold difference 0.5-9.2). There was little binding of IgG among samples from nonexposed donors (mean fluorescence 27.1±2 for CS2-wt; 7.4±1.4 for CS2∆SBP1), and
IgG binding of PNG sera was significantly higher than IgG binding of non-exposed sera for both CS2 and CS2∆SBP1 infected erythrocytes (p<0.001; Mann-Whitney U-test).
Interestingly, the response of these individuals against the CS2∆SBP1-infected erythrocytes was almost as low as that of the non-exposed individuals (Fig. 5C ). Sera from multigravid women also had antibodies to non-CSA binding parasite variants as expected for adults exposed to year-round malaria (data not shown). This is consistent with the lack of PfEMP1 on the surface of the CS2∆SBP1 infected-erythrocytes and demonstrates the major reactivity of antibodies from multigravid malaria-infected individuals is directed towards a protein that requires PfSBP1 for appropriate erythrocyte surface localization.
PfEMP1 loading into Maurer's clefts is impaired in CS2∆SBP1-infected erythrocytes
Since the transport of PfEMP1 onto the surface of the CS2∆SBP1-parasitized erythrocytes was dramatically altered we were interested in the localisation of PfEMP1 in these cells compared to CS2. PfEMP1 is translocated from the parasite across the parasitophorous vacuole by an unknown mechanism. It then associates with Maurer's clefts before a proportion is transferred onto the erythrocyte surface at approximately 16-18 hr post invasion 33 . In immunofluorescence assays the CS2 parental parasitised erythrocytes showed a typical pattern of PfEMP1 localisation with anti-ATS antibodies.
Protein was detected within the parasite but a significant proportion localised to punctate structures within the erythrocyte cytosol (Fig. 6A, upper panel) . These structures were identified as Maurer's clefts since PfEMP1 co-localised with the Maurer's cleft resident protein MAHRP1 (Fig. 6B , upper panel and Supp. Fig. 1 ). In contrast, the CS2∆SBP1
showed PfEMP1 localisation associated with the parasite and a high concentration around the periphery of the parasite and parasitophorous vacuole but there was little or no protein detectable in the erythrocyte (Fig. 6A, lower panel) . Co-localisation experiments with anti-MAHRP1 antibodies confirmed that no PfEMP1 was associated with Maurer's clefts in the transgenic cell line (Fig. 6B , lower panel and Supp. Fig. 2 ).
To further investigate the impaired transport of PfEMP1 in CS2∆SBP1-infected erythrocytes we transfected both parental and PfSBP1 disrupted parasite lines with a plasmid expressing a truncated form of PfEMP1 (Fig. 6C Fig. 6C ).
However, in erythrocytes infected with CS2∆SBP1 parasites the PfEMP1-YFP fusion gene could barely be detected in the erythrocyte cytosol, the vast majority being retained within the confines of the parasitophorous vacuole. This strongly suggests that PfSBP1 function is required for localisation of PfEMP1 to Maurer's clefts.
PfEMP1 trafficking to Maurer's clefts can be restored in SBP1 complemented cells
To explore this further we transfected the CS2∆SBP1-transgenic parasite line with the plasmid pCC-4/SBP1, where the PfSBP1 gene was inserted between the PfHSP86 promoter and the P.berghei DT terminator. Cells containing this plasmid were selected by the addition of blasticidin-S, since the plasmid contains blasticidin-S-deaminase as a selectable marker. Samples were taken from a stable population at different time points, saponin-lysed and analysed on Western blot probed with anti-SBP1 antibodies. A constant expression was detected throughout the different life cycle stages consistent with expression from the PfHSP86 promoter (Fig. 7A) . In contrast, CS2 showed almost no expression in ring stages and the highest relative expression in trophozoite stages as previously reported 18 . An immunofluorescence assay on erythrocytes infected with the CS2∆SBP1 showed that in complemented cells expressing PfSBP1 from the plasmid, PfEMP1 is transported efficiently beyond the parasitophorous vacuole membrane into the erythrocytes and co-localises in Maurer's clefts with PfSBP1 (Fig. 7B ). This shows that the PfEMP1 transport deficiency in the CS2∆SBP1 cells can be complemented by PfSBP1 expressed from an episomally maintained plasmid and confirms its requirement for transport of PfEMP1 to the erythrocyte surface. Furthermore it demonstrates that only the PfSBP1 gene was targeted by the knock out experiment and this gene alone is responsible for incorrect trafficking of PfEMP1.
Discussion
The P.falciparum-infected erythrocyte undergoes a remarkable series of modifications Previous reports suggest that PfEMP1 is transported through the P.falciparum-infected erythrocyte as complexes rather than within membranous vesicles 15, 32 . These findings were also supported by the solubility characteristics of PfEMP1 in the erythrocyte cytosol, which are inconsistent with trafficking in small membranous vesicles 32 . The demonstration that PfSBP1 is required for transfer of PfEMP1 from the PVM to Maurer's clefts suggests that the protein is most likely loaded directly into these structures rather than being released into the erythrocyte cytosol. It is also possible that PfSBP1 has a chaperone-like function allowing interaction with PfEMP1, which is required for trafficking out of the parasitophorous vacuole and association with Maurer's clefts.
The membrane association of PfEMP1 seems to be essential for correct trafficking of PfEMP1 via Maurer's clefts onto the surface of infected erythrocytes 15 . At least three PfEMP1 populations have been described outside the parasite differing in their solubility characteristics: PfEMP1 on the erythrocyte surface, an intracellular peripheral membrane protein pool and intracellular protein with solubility characteristics of the cell surface population 32 . In CS2∆SBP1 cells the surface exposed PfEMP1 is absent (Figs 4, 5A, 5E ).
At the same time the pool of intracellular peripheral membrane protein is increased ( Fig   5C) . One explanation for the slight increase of soluble PfEMP1 found in the erythrocyte cytosol in the SLO experiment could be transport of soluble PfEMP1 across the PVM.
Dilution in the cytosolic volume would explain the inability of detecting PfEMP1 via IFA. The second possibility is that during SLO treatment the PVM may become marginally leaky (as seen in Fig 5D CS2 supernatant) . This leakiness would have no impact on the membrane associated PfEMP1 in the wild type, but in the absence of PfSBP1 and consequent loss of membrane association it may leak into the erythrocyte cytosol more readily.
Whilst this manuscript was under review a similar study by Cooke et al. 34 Previously it had been suggested that PfSBP1 was conserved in other malaria species due to the reactivity of anti-PfSBP1 antibodies with other mouse malaria species 16 . However, with the availability of genome data for several Plasmodium species no orthologues of
PfSBP1 have yet been identified except in P.reichenowi. PfSBP1 is located in the subtelomeric region of chromosome 5 in the P.falciparum genome as part of a coexpressed cluster of genes. Of these, PFE0050w, PFE0055c and PFE0060w (together with PfSBP1, PFE0065w) are exported to the erythrocyte as shown by proteomic analysis 36 . This is coherent with most of them containing an identifiable PEXEL for transport across the PVM (except PfSBP1) 2 . The absence of a PEXEL in PfSBP1 is consistent with it being loaded directly into Maurer's clefts as suggested for another
Maurer's cleft resident protein MAHRP 28 . However, it is still possible that PfSBP1 crosses the PVM by being escorted with a PEXEL containing protein, or secondly, that it contains a non-typical transport motif not easily recognisable. Whilst the cluster of genes surrounding PfSBP1 have no identifiable orthologues in other Plasmodia the chromosomal region located more directly centromeric contains genes showing synteny in other species. This suggests the cluster of genes including PfSBP1 encode roles unique to P.falciparum and are likely to be associated with trafficking or function of PfEMP1.
Interestingly, one gene in this cluster (PFE0055c) contains a DNAJ domain and is annotated as a putative heat shock protein suggesting it may function as a co-chaperone.
Disruption of PfSBP1 expression resulted in a marked reduction in antibody binding to the surface of P.falciparum-infected erythrocytes using sera from exposed donors, which further supports our conclusion that trafficking of PfEMP1 is impaired in the transgenic line. PfEMP1 is believed to be the major target of acquired antibodies to the infected erythrocyte surface 37, 38 . CS2 infected erythrocytes express var2csa as the dominant var gene transcript 29 , and the same PfEMP1 was detected in western blots of both parental and CS2∆SBP1 parasites and therefore var2csa-PfEMP1 is likely to be the major target of antibodies to CS2 measured in our assays. Our data demonstrate that antibody binding to the parasitized erythrocyte surface antigens was greatly reduced using the PfSBP1 trafficking is solely due to loss of PfSBP1.
In conclusion, disruption of PfSBP1 in P.falciparum has shown that the protein is required for trafficking of the major virulence protein PfEMP1 from the parasite to
Maurer's clefts. Consequently, PfEMP1 cannot be displayed on the P.falciparum-infected erythrocyte surface resulting in loss of adherence. Although PfSBP1 is the first protein identified in P.falciparum directly involved in trafficking of PfEMP1 to the erythrocyte surface it is likely that a large number of proteins are required for its export and identification of PfSBP1 opens the way to identify other players in this crucial process pivotal to the pathogenesis of this human pathogen. The mean number of bound infected erythrocyte/mm 2 for CS2 parental binding was 1240 above bovine serum albumine control. complemented cells due to the episomal expression under a different promoter. DAPI was used to stain the nuclear DNA.
